Three-Month Outcomes Of Keratorefractive Lenticule Extraction Using Visumax 800 (Smile Pro) For Myopia Correction In Korean Patients
Published 2025 - 43rd Congress of the ESCRS
Reference: PO718 | Type: Free paper | DOI: 10.82333/krpa-ap68
Authors: Aymen Mabrouk* 1 , Hager Ben Amor 2 , Sarra El Mansouri 3 , Bechir Jelliti 2 , Moncef Khairallah 2
1ophtalmology departement,Farhat Hached University hospital ,Sousse ,Tunisia;ophtalmology departement,Fattouma Bourguiba University Hospital,Monastir,Tunisia, 2ophtalmology departement,Fattouma Bourguiba University Hospital,Monastir,Tunisia, 3ophtalmology departement,Farhat Hached University hospital ,Sousse ,Tunisia
Purpose
To report the clinical outcomes of the SMILE Pro surgery for myopia correction in Korean patients
Setting
Retrospective chart review at a single institution
Methods
A retrospective analysis was conducted on the medical records of 90 patients (178 eyes) who underwent SMILE Pro surgery at our institution between October 2023 and June 2024, with a 3 months postoperative follow-up.
Results
Preoperative best-corrected visual acuity (BCVA) was 0.009 ± 0.020 logMAR. The mean spherical equivalent was –5.13 ± 2.16 D (range: –1.00 to –10.10 D), and the average astigmatism was –1.21 ± 0.91 D (range: 0 to –4.00 D). Postoperative uncorrected distance visual acuity (UDVA) at 1 day, 1 week, 1 month, and 3 months was 0.061 ± 0.054, 0.013 ± 0.027, 0.009 ± 0.023, 0.005 ± 0.021, respectively. At 3 months, the predictive accuracy for spherical equivalent was 100% within ±0.5 D and 98.9% within ±0.25 D. For astigmatism, the predictive accuracy was 99.4% within ±0.5 D and 97.2% within ±0.25 D. The efficacy and safety indices at 3 months were both 1.01 ± 0.05.
Conclusions
SMILE Pro surgery for myopia correction demonstrated excellent efficacy, safety, and predictive accuracy in Korean patients, with outcomes comparable to conventional SMILE surgery.